
MassMutual Ventures and Advance Venture Partners returned to back the relationship management tool provider’s latest round, which brought its overall funding to $120m.
Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.
HomeLane has now taken in over $104m of funding since it was founded, including a series E round backed by Pidilite Group.
Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.
The Ohara Pharmaceutical-backed small-molecule therapy developer has secured $11.8m from new and returning investors.
Toray Engineering has returned to back a $27.3m round for the surgical robot developer, investing alongside Dai-ichi Life and Medipal Innovation.
Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.
Atlassian Ventures and Salesforce Ventures have returned to back a primary and secondary series F round for the app security platform developer that included Koch Strategic Platforms.
The Progressive-backed neobank has secured the fresh funding at a reported $2.5bn valuation, seven months after it closed a $63m round.
Disease diagnostics technology developer Mammoth Biosciences is valued at over $1bn following funding rounds backed by investors including Amazon.